Tranexamic Acid in Exosome Facial Rejuvenation Protocols
Tranexamic Acid plays a key role in professional exosome facial rejuvenation treatments. A synthetic lysine derivative that inhibits plasminogen activation and UV-induced melanogenesis, reducing melanin transfer to keratinocytes.
Role of Tranexamic Acid in Exosome Facial Rejuvenation
Application of concentrated plant-based exosomes to deliver growth factors and signalling molecules for deep cellular regeneration and skin renewal Tranexamic Acid enhances this treatment through its targeted depigmentation properties, providing brightening support during and after the procedure.
Protocol Integration
In a typical exosome facial rejuvenation protocol, tranexamic acid can be utilised at several stages:
- Pre-treatment: Skin preparation with tranexamic acid-containing products to optimise treatment outcomes
- During treatment: Active tranexamic acid delivery through the treatment modality for enhanced penetration
- Post-treatment: Recovery support using tranexamic acid formulations to accelerate healing
Clinical Benefits
Combining tranexamic acid with exosome facial rejuvenation offers several advantages:
- Enhanced targeted depigmentation through professional delivery methods
- Improved treatment outcomes with medical-grade brightening support
- Reduced downtime and faster recovery when supported by tranexamic acid
Skymedic Products
Skymedic offers professional-grade tranexamic acid formulations specifically designed for integration with exosome facial rejuvenation protocols. All products manufactured under ISO 13485 standards.